Skip to main content
OpenTrials

Clinical trial condition

alpha 1-Antitrypsin Deficiency

Explore clinical trials studying alpha 1-Antitrypsin Deficiency. Study availability and eligibility vary by location and protocol.

100 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

alpha 1-Antitrypsin Deficiency trial results

Completed

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

NCT01684410

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +11 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • National Jewish Hospital Denver, Colorado, United States
  • Children's Hospital Boston Boston, Massachusetts, United States
  • UNC at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

Genomic Research in Alpha-1 Antitrypsin Deficiency

NCT01832220

Conditions
AATD, Alpha 1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Arizona Health Sciences Center Tucson, Arizona, United States
  • University of California - San Francisco San Francisco, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details
Completed

Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency

NCT00261833

Conditions
Alpha1-Proteinase Inhibitor Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Study Site Denver, Colorado, United States
  • Study Site Miami, Florida, United States
  • Study Site Hershey, Pennsylvania, United States
  • Study Site Tyler, Texas, United States
View all 28 locations
View Trial Details
Completed

Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults

NCT00295061

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • St Lukes-Roosevelt Hospital Center, New York New York, United States
View Trial Details
Completed

The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency

NCT00301366

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • St Lukes-Roosevelt Hospital Center, New York New York, United States
View Trial Details
Completed

Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency

NCT01213043

Conditions
Alpha 1-antitrypsin Deficiency (AATD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University of Florida College of Medicine Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Temple University Hosptial/Temple Lung Center Philadelphia, Pennsylvania, United States
  • Medical University of South Carolina, Division of Pulmonary and Critical Care Medicine Charleston, South Carolina, United States
View Trial Details
Completed

Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)

NCT01419158

Conditions
Alpha-1 Antitrypsin Deficiency, Chronic Disease, Chronic Obstructive Pulmonary Disease, +14 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida (Gainesville) Gainesville, Florida, United States
  • University of Florida (Jacksonville) Jacksonville, Florida, United States
View all 19 locations
View Trial Details

Related conditions